BriaCell (BCTX) Therapeutics announces that it has accepted the resignation of Mr. Marc Lustig, MSc, MBA from the Board of Directors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCTX:
- BriaCell Advances Cancer Treatment with New Trial
- BriaCell announces first patient dosed with Bria-OTS in Phase 1/2 study
- BriaCell Shows Promise in Cancer Immunotherapy Advances
- BriaCell reports preclinical data of personalized off-the-shelf immunotherapies
- BriaCell Unveils Promising Cancer Therapy Data